参考文献/References:
[1]胡付品,朱德妹.医疗机构碳青霉烯类耐药肠杆菌细菌感染防控指南简介[J].中国感染与化疗杂志,2018,8(3):331-335.[2]黄先琪,杜芳玲,魏丹丹,等.血流感染肺炎克雷伯菌pLVPK毒力质粒的分布及与耐药的关系[J].中国抗生素杂志,2019,44(6):727-731.[3]胡付品,郭燕,朱德妹,等.2017年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2018,18(3):241-251.[4]周庭银,倪语星,王明贵,等.血流感染实验诊断与临床诊治[M].第2版.上海:上海科学技术出版社,2014.[5]中华预防医学会医院感染控制分会,中华医学会感染病学分会,中国医院协会医院感染管理专业委员会,等.中国碳青霉烯耐药革兰阴性杆菌(CRO)感染预防与控制技术指引[J].中华医院感染学杂志,2019,29(13):2075-2080.[6]Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing:M100-S30[S].Wayne:CLSI,2020.[7]Cassini A,H?觟gberg LD,Plachouras D,et al.Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis [J].Lancet Infect Dis,2019,19(1):56-66.[8]刘卫平,海云婷,杨丽芳,等.某三级综合医院耐碳青霉烯肠杆菌科细菌流行特征及耐药性分析[J].中华医院感染学杂志,2020,30(19):2943-2948.[9]Escrihuela-Vidal F,Laporte J,Albasanz-Puig A,et al.Update on the management of febrile neutropenia in hematologic patients[J].Rev Esp Quimioter,2019,32(Suppl2):55-58.[10]胡付品,郭燕,朱德妹,等.2018年CHINET中国细菌耐药性监测[J].中国感染与化疗杂志,2020,20(1):1-10.[11]吴苗苗,杨丹红,潘红英,等.碳青霉烯耐药肠杆菌科细菌定植转血流感染危险因素分析[J].浙江医学,2022,44(12):1300-1303.[12]Hu Y,Ping Y,Li L,et al.A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisitiona-mong ICU patients[J].J Infect Dev Ctries,2016,10(3):208-213.[13]Zhang L,Zhai W,Lin Q,et a1.Carbapenem-resistant Entero-bacteriaceae in hematological patients:outcome of patients with carbapenem-resistant Enterobacteriaceae infection and risk factors for progression to infection after rectal colonization [J].Int J Antimicrob Agents,2019,54(4):527-529.[14]陈云波,嵇金如,应超群,等.2016至2017年全国血流感染细菌耐药监测(BRICS)报告[J].中华临床感染病杂志,2020,13(1):42-54.[15]Chamieh A,El- Hajj G,Zmerli O,et al.Carbapenem resistant organisms: A 9- year surveillance and trends at Saint George University Medical Center[J].J Infect Public Health,2020,13(12):2101-2106.[16]Tomczyk S,Zanichelli V,Grayson ML,et al.Control of Carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa in Healthcare Facilities: A Systematic Review and Reanalysis of Quasi-experimental Studies[J].Clin Infect Dis,2019,68(5):873-884.[17]Durante-Mangoni E,Andini R,Zampino R.Management of carbapenem- resistant Enterobacteriaceae infections[J].Clin Microbiol Infect,2019,25(8):943-950.[18]黄细莲,吴盛海,施鹏飞,等.血液科患者肠道碳青霉烯类耐药的肠杆菌科细菌主动筛查及其效果评价[J].中华血液学杂志,2020,41(11):932-936.[19]Palacios-Baena ZR,Giannella M,Manissero D,et al.Risk factors for carbapenem-resistant gram-negative bacterial infections:A systematic review[J].Clin Microbiol Infect,2021,27(2):228-235.[20]Tran D,Larsson M,Olson L,et al.High prevalence of colonisation with carbapenem-resistant enterObacteriaceae among-patients admitted to Vietnamese hospitals:risk factors and burden of disease[J].J Infect,2019,79(2):115-122.[21]徐春晖,宿扬,吕燕霞,等.肛周皮肤拭子细菌培养对血液病患者耐碳青霉烯类肠杆菌血流感染的预警价值[J].中华血液学杂志,2018,39(12):1021-1025.